Health Care & Life Sciences » Pharmaceuticals | Foamix Pharmaceuticals Ltd.

Foamix Pharmaceuticals Ltd. | Income Statement

Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Sales/Revenue
1,404.00
5,414.00
849.00
5,527.00
3,669.00
3,595
Cost of Goods Sold (COGS) incl. D&A
453.00
527.00
113.50
202.00
234.00
319
Gross Income
951.00
4,887.00
735.50
5,325.00
3,435.00
3,276
SG&A Expense
2,307.00
6,521.00
17,665.50
34,975.00
69,049.00
78,168
EBIT
1,356.00
1,634.00
16,930.00
29,650.00
65,614.00
74,892
Unusual Expense
69.00
-
-
-
-
-
Non Operating Income/Expense
27.00
71.00
163.00
408.00
531.00
644
Interest Expense
1,117.00
9,915.00
-
243.00
-
-
Pretax Income
2,431.00
11,478.00
16,478.00
28,949.00
64,551.00
73,951
Income Tax
-
6.00
39.00
387.00
1,164.00
212
Consolidated Net Income
2,431.00
11,484.00
16,517.00
29,336.00
65,715.00
74,163
Net Income
2,431.00
11,484.00
16,517.00
29,336.00
65,715.00
74,163
Net Income After Extraordinaries
2,431.00
11,484.00
16,517.00
29,336.00
65,715.00
74,163
Net Income Available to Common
2,431.00
11,484.00
16,517.00
29,336.00
65,715.00
74,163
EPS (Basic)
0.01
0.79
0.59
0.91
1.76
1.70
Basic Shares Outstanding
180,559.00
14,512.00
28,229.00
32,263.00
37,376.00
43,660
EPS (Diluted)
0.01
0.79
0.59
0.91
1.76
1.70
Diluted Shares Outstanding
180,559.00
14,512.00
28,229.00
32,263.00
37,376.00
43,660
EBITDA
1,317.00
1,601.00
16,843.00
29,507.00
65,393.00
74,573
Non-Operating Interest Income
-
-
289.00
536.00
532.00
297

About Foamix Pharmaceuticals

View Profile
Address
2 Holzman Street
Rehovot HM 76704
Israel
Employees -
Website http://www.foamixpharma.com
Updated 07/08/2019
Foamix Pharmaceuticals Ltd. is a pharmaceutical company, which focuses on the development and commercialization of proprietary, innovative and differentiated topical drugs for dermatological therapy. Its product portfolios include minocycline foam, minocycline gel, mometasone foam, calcipotriene foam, triamcinolone acetonide foam, betamethasone valerate foam, and betamethasone dipropionate. The company was founded by Dov Tamarkin and Meir Eini on January 19, 2003 and is headquartered in Rehovot, Israel.